Posted by Michael Wonder on 27 Jul 2020
EMA starts review of dexamethasone for treating adults with COVID-19 requiring respiratory support
24 July 2020 - EMA is reviewing results from the RECOVERY study arm that involved the use of dexamethasone in the treatment of patients with COVID-19 admitted to hospital.
This part of the study looked into the effects of adding dexamethasone to usual care in adults receiving invasive ventilation, those given oxygen (e.g. through a mask) or those receiving no oxygen. Invasive ventilation involves use of a machine to push air through a tube inserted into the patient’s airway.
